Rubix Life Sciences

Digitally connecting patients, especially minorities, to clin...

Fundraise Status
Goal Amount
Amount Raised


Rubix LS is a companion research and development organization designing digital health tools. We help the global population access digital health tools at scale for faster access to clinical therapies. Our flagship product, Starsense® is already serving clients.


Challenges in recruiting minority patients to clinical trials has limited medical research.

Medical research on minorities has a dubious history, and many feel their doctors withhold information.

As much as 80% of underrepresented patients are unaware of options to be included within a clinical trial geared toward a specific therapeutic indication.


Our mission is to ensure that therapeutics and vaccines developed within the life science industry factor in every patient ethnicity and demographics to bolster product efficacy, health equity, and effective patient outcomes.

We’re helping our partners design early-stage research and development that encompasses diverse data sets to drive therapeutic innovation.

StarSense, our lead virtual clinical trial platform, is a wholly engaged environment to specifically model patient sociology, genetics & epidemiological surveillance to enhance patient depth and engagement and recruitment.

We’re solving access to digital health and clinical trials as treatment options for minorities and the greater population by providing:

  • Direct clinical trial recruitment and onboarding virtually
  • First-hand access to clinical trials virtually
  • Educative and heuristic/gamification modules to provide immersive clinical trial history as well as specific transparency on therapeutic indication targeted
  • Customized patient prognosis and monitoring analytics for individual patient outcomes, while conducting proactive clinical trial success projections


Rubix LS offers a range of technology-based services to be deployed by our partners.

We work with doctors, scientists and consultants to ensure patients get the highest level of care. And we provide education so clients can get a clearer sense of what they need for their health and how to get it.

Project Hercules: Rare & orphan disease R&D

Project Icarus: Setting the stage on how to attack malformations of the brain that leads up to cancerous development of tumors that are diagnosed DIPG grade IV

Project Kronos: Amassing health data information to map predictive analytics and using artificial intelligence to map deeper disease intelligence gaps

StarSense: Suite of digital health tools that produce virtual clinical trials to engage minorities and populations globally



Reginald Swift, Ph.D, CEO, is a kinesthetic entrepreneur with 16 years of mechanical engineering experience from research, academic and industry based perspectives. His range of experiences stems from aerospace & defense, robotics, nuclear technologies, biotechnology/life-sciences, and astronautics. Including his work in industry, he has a strong quality transformation and technological development experience that has been implemented in countless organizations from start-up to Fortune 100 organizations.

Americo Diaz, Chief Engineer, has been lead engineer on many initiatives, ranging from Draper Labs, the United Nations (Tropical Disease Initiatives), Robotic enabled therapeutics from Academia at WPI (Worcester Polytech) to startups.

Tara Cassineau, Chief Scientist/Researcher, was lead investigator for pharmaceutical development approvals in Canada Medicines Authority (CMDCAS). She worked for European conglomerates, including Mallinckrodt, Merck KGaA, The Fisher Initiative and more on high-tech pharmaceutical research.

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.

Request Access


No updates yet.


No backers yet.

Quick Signup TBD

You must have an account to do this!

the platform

Copyright © 2019 All rights reserved.

Fundable is a software as a service funding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.